Trial Profile
Long term efficacy and safety of Ledipasvir and Sofosbuvir in patients with hepatitis C virus related cryoglobulinaemia without renal involvement
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Feb 2018
Price :
$35
*
At a glance
- Drugs Ledipasvir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 28 Feb 2018 New trial record
- 13 Feb 2018 Results published in the Clinical and Experimental Rheumatology